Meanwhile, after the antiviral treatment, the frequency, and the absolute number of CD8+ T cells significantly decreased in the peripheral blood during the early convalescent phase of EBV infection (Figure 5, A,C, Supplementary Figure S4B). The gene discussed is CD8A; the disease is Epstein-Barr virus infection.